Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal AntibodiesMaria Silvia Cona, Massimo Di Nicola, Michele Del Vecchio et al.|Cancers|2019Cited by 30
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective studySebastiano Buti, Nunziata D’Abbiero, Melissa Bersanelli et al.|Cancer Treatment and Research Communications|2019Cited by 25